Wealth Alliance’s ResMed RMD Stock Holding History

Wealth Alliance’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-978	Closed	-$268K	–	590
2025 Q3	$268K	Sell	978 -218	-18%	-$59.5K	0.03%	455
2025 Q2	$309K	Buy	+1,196	New	+$285K	0.03%	400

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Wealth Alliance's RMD Position: Q4 2025 in Review

Wealth Alliance sold out of ResMed (RMD) in Q4 2025, closing a stake of 978 shares — an estimated $268K sold.

Wealth Alliance first reported a position in RMD in Q2 2025 and held it in 2 quarters. The position peaked at $309K in Q2 2025. 948 funds tracked by Wall St. Rank hold RMD as of Q4 2025.

Wealth Alliance reported no remaining ResMed position as of Q4 2025 after selling out during the quarter.
Wealth Alliance sold 978 ResMed shares in Q4 2025, an estimated $268K.
Wealth Alliance first reported a position in ResMed in Q2 2025 and held it in 2 quarters.
Wealth Alliance's ResMed position peaked at $309K in Q2 2025.
948 funds tracked by Wall St. Rank held ResMed as of Q4 2025.

Based on Wealth Alliance's 13F filing for Q4 2025, filed 13 Feb 2026.